down arrow

Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
244.45
9.45 (4.02%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 52.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Wanbury Ltd stock-summary
stock-summary
Wanbury Ltd
Micro Cap
Pharmaceuticals & Drugs
Wanbury Ltd (Formerly known Pearl Organics Limited) was incorporated in August, 1988. The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs. In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga. In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US.
Company Coordinates stock-summary
Company Details
BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat Navi Mumbai Maharashtra : 400703
stock-summary
Tel: 91-22-67942222
stock-summary
shares@wanbury.com
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 32.76 Cr
Number of Shares
3.28 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-Aug-2024
3.28
32.76
15000
10
Issued under ESOP Scheme
20-Oct-2023
3.27
32.75
10000
10
Issued under ESOP Scheme
11-Aug-2023
3.27
32.74
15000
10
Issued under ESOP Scheme
07-Jul-2023
3.27
32.72
15000
10
Issued under ESOP Scheme
28-Nov-2022
3.27
32.71
10000
10
Issued under ESOP Scheme
22-Jun-2022
3.27
32.70
30000
10
Issued under ESOP Scheme
20-Oct-2021
3.27
32.67
10000
10
Issued under ESOP Scheme
28-Jun-2021
3.27
32.66
25000
10
Issued under ESOP Scheme
22-Apr-2021
3.26
32.63
7615381
10
Preferential basis
11-Sep-2020
2.5
25.02
20000
10
Issued under ESOP Scheme
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

76.7355

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 4 FIIs (1.02%)

Promoter with highest holding

Expert Chemicals (india) Pvt Ltd (30.53%)

Highest Public shareholder

Authum Investment And Infrastructure Limited (2.34%)

Individual Investors Holdings

40.66%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
N K Puri
Independent Director
8.25 lacs
K Chandran
Vice Chairman & Whole Time Dir
0
Jitendra J Gandhi
Company Sec. & Compli. Officer
0
Pallavi Shedge
Independent Director
8.25 lacs
Binod Chandra Maharana
Independent Director
8.25 lacs
Manisha Juvekar
Independent Director
8.25 lacs
Anupam Vaidya
Independent Director
1.25 lacs
Pravin Dilip Pawar
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Finished Goods/Bulk Drugs
249.56
66.70%
Traded Goods
121.07
32.36%
Export Incentive
2.61
0.70%
 
66.7
Finished Goods/Bulk Drugs
33.3
Finished Goods/Bulk Drugs
32.36
Traded Goods
67.64
Traded Goods
0.7
Export Incentive
99.3
Export Incentive
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
133 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 787 Cr (Micro Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

4.36

stock-summary
Return on Equity

71.23%

stock-summary
Price to Book

19.87